| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR51A2 GPR4 NPY6R NPY5R OR9G1 LPAR5 GPR26 FZD3 OR5D18 GPR37 GPR82 MC1R TMEM63C OR1F12P ABCC9 OR1A2 GPR183 SSTR3 ABCA7 CHRNA1 CHRNA2 CHRNB1 CHRNB4 OR9G9 CHRND OPRD1 CHRNE OPRK1 CHRNG OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 ABCC8 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 1.62e-23 | 1353 | 99 | 42 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR51A2 GPR4 NPY6R NPY5R OR9G1 LPAR5 GPR26 FZD3 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 1.66e-18 | 884 | 99 | 31 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 ATP13A4 SLC7A13 SLC6A16 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 SLC44A4 SLCO6A1 ABCA7 ABCA10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 MFSD14A SLC44A5 KCNC3 SLC26A7 KCNG1 SLC22A13 ABCC8 NIPAL2 NIPA1 | 5.25e-15 | 1180 | 99 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 ATP13A4 ATP8B4 SLC7A13 SLC6A16 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 SLC44A4 SLCO6A1 ABCA7 ABCA10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 MFSD14A SLC44A5 KCNC3 SLC26A7 KCNG1 SLC22A13 ABCC8 NIPAL2 NIPA1 | 8.18e-15 | 1289 | 99 | 32 | GO:0005215 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.11e-12 | 17 | 99 | 7 | GO:0022848 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 ATP13A4 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 9.42e-12 | 664 | 99 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.36e-11 | 23 | 99 | 7 | GO:0015464 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 ATP13A4 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 NIPAL2 NIPA1 | 3.57e-11 | 793 | 99 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG ABCC8 | 1.01e-10 | 140 | 99 | 11 | GO:0099094 |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 KCNV2 TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 | 7.99e-10 | 525 | 99 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 KCNV2 TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 | 8.22e-10 | 526 | 99 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | gated channel activity | KCNV2 TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 | 1.08e-09 | 334 | 99 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.15e-09 | 133 | 99 | 10 | GO:0008528 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | KCNV2 TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 | 1.52e-09 | 343 | 99 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.65e-09 | 43 | 99 | 7 | GO:0005231 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.90e-09 | 140 | 99 | 10 | GO:0001653 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG ABCC8 | 3.11e-09 | 193 | 99 | 11 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG ABCC8 | 3.86e-09 | 197 | 99 | 11 | GO:0022834 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNV2 TMEM63C ABCC9 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 SLC26A7 KCNG1 ABCC8 | 7.75e-09 | 459 | 99 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.28e-08 | 57 | 99 | 7 | GO:1904315 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 ATP13A4 SLC7A13 SLC6A16 SLC5A7 ABCC9 SLC6A15 SLC44A4 SLCO6A1 ABCA7 ABCA10 SLC12A5 SLC44A5 SLC26A7 ABCC8 | 1.30e-08 | 477 | 99 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.85e-08 | 60 | 99 | 7 | GO:0099529 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.62e-08 | 37 | 99 | 6 | GO:0042923 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.27e-08 | 65 | 99 | 7 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.27e-08 | 65 | 99 | 7 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 8.95e-08 | 75 | 99 | 7 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.08e-07 | 77 | 99 | 7 | GO:0005230 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 3.93e-07 | 13 | 99 | 4 | GO:0042166 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 6.53e-07 | 100 | 99 | 7 | GO:0030594 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 1.49e-06 | 431 | 99 | 12 | GO:0004984 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC7A13 SLC6A16 SLC5A7 SLC6A15 SLC44A4 SLCO6A1 SLC12A5 SLC44A5 SLC26A7 | 2.14e-06 | 296 | 99 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 ATP13A4 KCNV2 SLC5A7 ABCC9 SLC6A15 SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 3.26e-06 | 465 | 99 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 ATP13A4 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 NIPAL2 NIPA1 | 4.73e-06 | 758 | 99 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 6.43e-06 | 53 | 99 | 5 | GO:0008188 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 6.50e-06 | 8 | 99 | 3 | GO:0015220 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 ATP13A4 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 1.32e-05 | 627 | 99 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.97e-05 | 167 | 99 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | orexin receptor activity | 2.43e-05 | 2 | 99 | 2 | GO:0016499 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor activity | 2.43e-05 | 2 | 99 | 2 | GO:0008281 | |
| GeneOntologyMolecularFunction | peptide binding | 2.90e-05 | 318 | 99 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.01e-04 | 49 | 99 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.27e-04 | 301 | 99 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 1.54e-04 | 102 | 99 | 5 | GO:0005249 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.10e-04 | 109 | 99 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | peptide YY receptor activity | 2.41e-04 | 5 | 99 | 2 | GO:0001601 | |
| GeneOntologyMolecularFunction | ATP-activated inward rectifier potassium channel activity | 3.60e-04 | 6 | 99 | 2 | GO:0015272 | |
| GeneOntologyMolecularFunction | potassium channel activity | 4.42e-04 | 128 | 99 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 5.03e-04 | 7 | 99 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 8.56e-04 | 9 | 99 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | symporter activity | 9.08e-04 | 150 | 99 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 9.63e-04 | 152 | 99 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.30e-03 | 11 | 99 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 1.54e-03 | 46 | 99 | 3 | GO:0050997 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.55e-03 | 12 | 99 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.62e-03 | 171 | 99 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | hormone binding | 1.73e-03 | 103 | 99 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.94e-03 | 178 | 99 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.07e-03 | 51 | 99 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.13e-03 | 182 | 99 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.24e-03 | 184 | 99 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 2.57e-03 | 55 | 99 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.92e-03 | 119 | 99 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 3.30e-03 | 60 | 99 | 3 | GO:0005544 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.40e-03 | 293 | 99 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.48e-03 | 125 | 99 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 3.54e-03 | 18 | 99 | 2 | GO:0015095 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 3.62e-03 | 62 | 99 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 4.81e-03 | 21 | 99 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.95e-03 | 138 | 99 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 5.75e-03 | 23 | 99 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.79e-03 | 151 | 99 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 7.32e-03 | 26 | 99 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 7.88e-03 | 27 | 99 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 8.16e-03 | 83 | 99 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 8.46e-03 | 28 | 99 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 8.46e-03 | 28 | 99 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 8.46e-03 | 28 | 99 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 1.03e-02 | 31 | 99 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | receptor serine/threonine kinase binding | 1.30e-02 | 35 | 99 | 2 | GO:0033612 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 GPR4 NPY6R NPY5R OR9G1 LPAR5 GPR26 FZD3 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 2.01e-13 | 1395 | 99 | 31 | GO:0007186 |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 3.25e-11 | 44 | 99 | 8 | GO:0007271 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 ATP13A4 SLC6A16 WFS1 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 NIPAL2 NIPA1 | 9.36e-10 | 1374 | 99 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 ATP13A4 SLC6A16 KCNV2 TMEM63C ABCC9 SLC6A15 ANO10 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 CHRNG SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 NIPAL2 NIPA1 | 2.12e-09 | 1115 | 99 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 ATP13A4 SLC6A16 WFS1 KCNV2 SLC5A7 TMEM63C ABCC9 SLC6A15 ANO10 CHRNA1 CHRNB1 CHRND OPRD1 CHRNE OPRK1 CHRNG SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 4.29e-09 | 1157 | 99 | 23 | GO:0006812 |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 4.61e-09 | 51 | 99 | 7 | GO:0095500 | |
| GeneOntologyBiologicalProcess | synaptic signaling | SLC12A6 NPY5R SLC5A7 LRIT3 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 CHRNG SLC12A5 OXTR MCTP1 KCNC3 P2RY2 ABCC8 MCTP2 HCRTR1 HCRTR2 | 5.81e-09 | 976 | 99 | 21 | GO:0099536 |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 6.09e-09 | 53 | 99 | 7 | GO:1905145 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 9.06e-09 | 56 | 99 | 7 | GO:1905144 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC12A6 NPY5R SLC5A7 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 CHRNG SLC12A5 OXTR MCTP1 KCNC3 P2RY2 ABCC8 MCTP2 HCRTR1 HCRTR2 | 1.46e-08 | 931 | 99 | 20 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC12A6 NPY5R SLC5A7 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 CHRNG SLC12A5 OXTR MCTP1 KCNC3 P2RY2 ABCC8 MCTP2 HCRTR1 HCRTR2 | 1.46e-08 | 931 | 99 | 20 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | SLC12A6 NPY5R SLC5A7 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 CHRNG SLC12A5 OXTR MCTP1 KCNC3 P2RY2 ABCC8 MCTP2 HCRTR1 HCRTR2 | 1.69e-08 | 939 | 99 | 20 | GO:0099537 |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 4.00e-08 | 69 | 99 | 7 | GO:0098926 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 1.47e-07 | 124 | 99 | 8 | GO:0007218 | |
| GeneOntologyBiologicalProcess | response to nicotine | 3.47e-07 | 58 | 99 | 6 | GO:0035094 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 5.62e-07 | 485 | 99 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 EPS8L2 OR9G1 WFS1 OR5D18 MC1R OR1F12P PRPH2 OR1A2 LRIT3 OR9G9 OPRK1 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 6.95e-07 | 1072 | 99 | 19 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P PRPH2 OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 7.28e-07 | 582 | 99 | 14 | GO:0050906 |
| GeneOntologyBiologicalProcess | behavior | NPY5R LPAR5 WFS1 GPR37 MC1R ABCA7 CHRNB1 CHRNB4 OPRD1 OPRK1 SLC12A5 OXTR P2RY2 ABCC8 ABHD12 HCRTR1 HCRTR2 | 1.07e-06 | 891 | 99 | 17 | GO:0007610 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 1.09e-06 | 432 | 99 | 12 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 1.33e-06 | 524 | 99 | 13 | GO:0009593 |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.91e-06 | 121 | 99 | 7 | GO:0051899 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 2.14e-06 | 547 | 99 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 2.35e-06 | 465 | 99 | 12 | GO:0007608 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | KCNV2 ABCC9 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE CHRNG KCNC3 KCNG1 ABCC8 | 2.72e-06 | 559 | 99 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 3.09e-06 | 130 | 99 | 7 | GO:0060079 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 4.37e-06 | 259 | 99 | 9 | GO:0006836 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 5.00e-06 | 52 | 99 | 5 | GO:0003009 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 6.97e-06 | 147 | 99 | 7 | GO:0099565 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P PRPH2 OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 8.86e-06 | 722 | 99 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 ATP13A4 SLC6A16 KCNV2 TMEM63C ABCC9 SLC6A15 ANO10 CHRNE OPRK1 SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 1.01e-05 | 942 | 99 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | choline transport | 1.26e-05 | 10 | 99 | 3 | GO:0015871 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.32e-05 | 162 | 99 | 7 | GO:0007631 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.61e-05 | 232 | 99 | 8 | GO:0071805 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 2.03e-05 | 69 | 99 | 5 | GO:0050881 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 ATP13A4 SLC6A16 WFS1 KCNV2 SLC5A7 ABCC9 SLC6A15 OPRD1 OPRK1 SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 2.12e-05 | 1000 | 99 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.60e-05 | 180 | 99 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 2.61e-05 | 36 | 99 | 4 | GO:0007274 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 2.67e-05 | 73 | 99 | 5 | GO:0050879 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | UBR1 AUP1 WFS1 RAPGEF1 ABCC9 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG BCAP31 OXTR P2RY2 ABCC8 | 3.14e-05 | 1272 | 99 | 18 | GO:1901698 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 4.40e-05 | 133 | 99 | 6 | GO:0007200 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 5.01e-05 | 272 | 99 | 8 | GO:0006813 | |
| GeneOntologyBiologicalProcess | action potential | 5.25e-05 | 201 | 99 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 ATP13A4 SLC6A16 KCNV2 ABCC9 SLC6A15 ANO10 OPRK1 SLC12A5 KCNC3 SLC26A7 KCNG1 ABCC8 NIPAL2 NIPA1 | 9.88e-05 | 1017 | 99 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 1.05e-04 | 51 | 99 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | acetate ester biosynthetic process | 1.36e-04 | 4 | 99 | 2 | GO:1900620 | |
| GeneOntologyBiologicalProcess | acetylcholine biosynthetic process | 1.36e-04 | 4 | 99 | 2 | GO:0008292 | |
| GeneOntologyBiologicalProcess | eating behavior | 1.51e-04 | 56 | 99 | 4 | GO:0042755 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | UBR1 RAPGEF1 ABCC9 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE CHRNG P2RY2 | 2.56e-04 | 752 | 99 | 12 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 2.62e-04 | 118 | 99 | 5 | GO:0046928 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 3.57e-04 | 195 | 99 | 6 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 3.57e-04 | 195 | 99 | 6 | GO:0007269 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum calcium ion homeostasis | 3.58e-04 | 29 | 99 | 3 | GO:0032469 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 ATP13A4 SLC6A16 KCNV2 ABCC9 SLC6A15 OPRK1 SLC12A5 KCNC3 KCNG1 ABCC8 NIPAL2 NIPA1 | 4.60e-04 | 922 | 99 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | SLC12A6 UBR1 GPR37 RAPGEF1 ABCC9 SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG P2RY2 ABCC8 | 5.07e-04 | 1450 | 99 | 17 | GO:1901701 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 5.94e-04 | 141 | 99 | 5 | GO:0051588 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum calcium ion concentration | 6.27e-04 | 8 | 99 | 2 | GO:0032471 | |
| GeneOntologyBiologicalProcess | acetate ester metabolic process | 6.27e-04 | 8 | 99 | 2 | GO:1900619 | |
| GeneOntologyBiologicalProcess | acetylcholine metabolic process | 6.27e-04 | 8 | 99 | 2 | GO:0008291 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 6.29e-04 | 217 | 99 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | organic cation transport | 6.74e-04 | 145 | 99 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.87e-04 | 400 | 99 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 7.59e-04 | 225 | 99 | 6 | GO:0050905 | |
| GeneOntologyBiologicalProcess | positive regulation of penile erection | 8.03e-04 | 9 | 99 | 2 | GO:0060406 | |
| GeneOntologyBiologicalProcess | organic anion transport | NPY5R SLC7A13 SLC6A15 SLC44A4 SLCO6A1 P2RY2 SLC26A7 SLC22A13 ABCC8 | 8.32e-04 | 515 | 99 | 9 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.59e-04 | 153 | 99 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 1.22e-03 | 11 | 99 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | regulation of penile erection | 1.22e-03 | 11 | 99 | 2 | GO:0060405 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.27e-03 | 547 | 99 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | penile erection | 1.46e-03 | 12 | 99 | 2 | GO:0043084 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 1.72e-03 | 13 | 99 | 2 | GO:0038003 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 1.72e-03 | 13 | 99 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | positive regulation of feeding behavior | 1.72e-03 | 13 | 99 | 2 | GO:2000253 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.73e-03 | 359 | 99 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.90e-03 | 183 | 99 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue growth | 2.00e-03 | 14 | 99 | 2 | GO:0048630 | |
| GeneOntologyBiologicalProcess | hypotonic response | 2.00e-03 | 14 | 99 | 2 | GO:0006971 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | SLC12A6 GPR4 FZD3 NOC2L MC1R PRPH2 ABCC9 ABCA7 LRIT3 OPRD1 SLC12A5 VAC14 OXTR ABCC8 ABHD12 | 2.07e-03 | 1361 | 99 | 15 | GO:0009628 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.09e-03 | 112 | 99 | 4 | GO:1902476 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.31e-12 | 18 | 99 | 7 | GO:0005892 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | KCNV2 ABCC9 SLCO6A1 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 ABHD12 | 2.97e-09 | 378 | 99 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | ATP8B4 KCNV2 ABCC9 SLCO6A1 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 ABHD12 | 4.67e-08 | 550 | 99 | 15 | GO:1990351 |
| GeneOntologyCellularComponent | transmembrane transporter complex | KCNV2 ABCC9 SLCO6A1 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 ABHD12 | 1.72e-07 | 523 | 99 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | synaptic membrane | FZD3 SLC5A7 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG SLC12A5 KCNC3 P2RY2 | 6.34e-07 | 583 | 99 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG SLC12A5 KCNC3 | 3.45e-06 | 405 | 99 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.55e-05 | 112 | 99 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | KCNV2 ABCC9 SLCO6A1 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 ABHD12 | 1.95e-05 | 785 | 99 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.30e-05 | 179 | 99 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.30e-05 | 179 | 99 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.83e-05 | 201 | 99 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | potassium ion-transporting ATPase complex | 6.64e-05 | 3 | 99 | 2 | GO:0031004 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC12A6 SLC7A13 FZD3 SLC5A7 SLC44A4 ABCA7 OXTR P2RY2 SLC26A7 SLC22A13 | 1.05e-04 | 487 | 99 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | inward rectifying potassium channel | 1.32e-04 | 4 | 99 | 2 | GO:0008282 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.37e-04 | 104 | 99 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.60e-04 | 350 | 99 | 8 | GO:0098802 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 4.90e-04 | 293 | 99 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 SLC7A13 FZD3 SLC5A7 SLC44A4 ABCA7 OXTR P2RY2 SLC26A7 SLC22A13 | 5.00e-04 | 592 | 99 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | synaptic vesicle | 5.64e-04 | 300 | 99 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | exocytic vesicle | 8.25e-04 | 320 | 99 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | cation channel complex | 8.88e-04 | 235 | 99 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | presynapse | NPY5R FZD3 WFS1 SLC5A7 OPRD1 OPRK1 VAC14 MCTP1 KCNC3 P2RY2 ABCC8 MCTP2 | 9.74e-04 | 886 | 99 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ATP13A4 AUP1 WFS1 OR5D18 GPR37 LRIT3 ESYT3 THADA BCAP31 MCTP1 CLMN VKORC1L1 ZDHHC22 LPGAT1 ABHD12 | 1.41e-03 | 1327 | 99 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | membrane protein complex | KCNV2 ABCC9 SLCO6A1 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE CHRNG VAC14 KCNC3 KCNG1 CLMN ABCC8 ABHD12 | 1.75e-03 | 1498 | 99 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | receptor complex | 1.75e-03 | 581 | 99 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.05e-03 | 277 | 99 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.38e-03 | 56 | 99 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ATP13A4 AUP1 WFS1 OR5D18 GPR37 LRIT3 ESYT3 THADA BCAP31 MCTP1 VKORC1L1 ZDHHC22 LPGAT1 ABHD12 | 3.06e-03 | 1293 | 99 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ATP13A4 AUP1 WFS1 OR5D18 GPR37 LRIT3 ESYT3 THADA BCAP31 MCTP1 VKORC1L1 ZDHHC22 LPGAT1 ABHD12 | 3.19e-03 | 1299 | 99 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | leading edge membrane | 3.25e-03 | 210 | 99 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ATP13A4 ATP8B4 WFS1 SLC5A7 RAPGEF1 ABCA7 CHRNB4 OPRD1 OPRK1 VAC14 MCTP1 SLC26A7 ABCC8 MCTP2 | 3.37e-03 | 1307 | 99 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | ATP13A4 ATP8B4 WFS1 SLC5A7 RAPGEF1 ABCA7 CHRNB4 OPRD1 OPRK1 VAC14 MCTP1 SLC26A7 ABCC8 MCTP2 | 3.80e-03 | 1325 | 99 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | perikaryon | 4.20e-03 | 223 | 99 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | neuron projection membrane | 6.96e-03 | 82 | 99 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | dendrite | FZD3 WFS1 GPR37 SLC5A7 LRIT3 OPRD1 OPRK1 SLC12A5 KCNC3 ABHD12 | 7.45e-03 | 858 | 99 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | FZD3 WFS1 GPR37 SLC5A7 LRIT3 OPRD1 OPRK1 SLC12A5 KCNC3 ABHD12 | 7.56e-03 | 860 | 99 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | early endosome | 7.91e-03 | 481 | 99 | 7 | GO:0005769 | |
| GeneOntologyCellularComponent | postsynapse | CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG SLC12A5 KCNC3 | 8.72e-03 | 1018 | 99 | 11 | GO:0098794 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 9.26e-03 | 91 | 99 | 3 | GO:0008076 | |
| GeneOntologyCellularComponent | cell leading edge | 9.67e-03 | 500 | 99 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 9.97e-03 | 503 | 99 | 7 | GO:0099572 | |
| HumanPheno | Anti-acetylcholine receptor antibody positivity | 1.23e-07 | 22 | 30 | 5 | HP:6001064 | |
| HumanPheno | Anti-neuromuscular Junction acetylcholine receptor antibody positivity | 1.23e-07 | 22 | 30 | 5 | HP:0030208 | |
| HumanPheno | EMG: decremental response of compound muscle action potential to repetitive nerve stimulation | 6.42e-07 | 30 | 30 | 5 | HP:0003403 | |
| HumanPheno | Fatigable weakness of neck muscles | 6.74e-07 | 13 | 30 | 4 | HP:0030199 | |
| HumanPheno | Decreased miniature endplate potentials | 6.74e-07 | 13 | 30 | 4 | HP:0003402 | |
| HumanPheno | Multiple pterygia | 7.35e-07 | 4 | 30 | 3 | HP:0001040 | |
| HumanPheno | Amyoplasia | 7.35e-07 | 4 | 30 | 3 | HP:0003634 | |
| HumanPheno | Decreased size of nerve terminals | 1.28e-06 | 15 | 30 | 4 | HP:0003443 | |
| HumanPheno | Hip flexor weakness | 1.28e-06 | 15 | 30 | 4 | HP:0012515 | |
| HumanPheno | EMG: impaired neuromuscular transmission | 1.66e-06 | 36 | 30 | 5 | HP:0100285 | |
| HumanPheno | Ankle weakness | 2.21e-06 | 17 | 30 | 4 | HP:0031374 | |
| HumanPheno | Triceps weakness | 2.83e-06 | 18 | 30 | 4 | HP:0031108 | |
| HumanPheno | Weakness of long finger extensor muscles | 4.44e-06 | 20 | 30 | 4 | HP:0009077 | |
| HumanPheno | Weakness of the intrinsic hand muscles | 9.57e-06 | 24 | 30 | 4 | HP:0009005 | |
| HumanPheno | Thoracic kyphoscoliosis | 9.57e-06 | 24 | 30 | 4 | HP:0005659 | |
| HumanPheno | Diplopia | 1.40e-05 | 94 | 30 | 6 | HP:0000651 | |
| HumanPheno | Abnormality of binocular vision | 1.40e-05 | 94 | 30 | 6 | HP:0011514 | |
| HumanPheno | Abnormality of masticatory muscle | 1.56e-05 | 27 | 30 | 4 | HP:0410011 | |
| HumanPheno | Drowsiness | 1.69e-05 | 57 | 30 | 5 | HP:0002329 | |
| HumanPheno | Reduced vital capacity | 2.10e-05 | 29 | 30 | 4 | HP:0002792 | |
| HumanPheno | Abnormality of jaw muscles | 2.76e-05 | 31 | 30 | 4 | HP:0045037 | |
| HumanPheno | Abnormal cervical curvature | 3.91e-05 | 12 | 30 | 3 | HP:0005905 | |
| HumanPheno | Aplasia of the musculature | 3.91e-05 | 12 | 30 | 3 | HP:0100854 | |
| HumanPheno | Proximal muscle weakness in upper limbs | 4.02e-05 | 68 | 30 | 5 | HP:0008997 | |
| HumanPheno | Functional motor deficit | SLC12A6 SLC5A7 ABCC9 CHRNA1 CHRNB1 CHRND CHRNE SLC12A5 KCNC3 ABCC8 | 1.19e-04 | 436 | 30 | 10 | HP:0004302 |
| HumanPheno | Fatigable weakness of skeletal muscles | 1.23e-04 | 45 | 30 | 4 | HP:0030197 | |
| HumanPheno | Neck flexor weakness | 1.34e-04 | 46 | 30 | 4 | HP:0003722 | |
| HumanPheno | Easy fatigability | 1.63e-04 | 91 | 30 | 5 | HP:0003388 | |
| HumanPheno | Weak cry | 1.72e-04 | 49 | 30 | 4 | HP:0001612 | |
| HumanPheno | Hand muscle weakness | 1.72e-04 | 49 | 30 | 4 | HP:0030237 | |
| HumanPheno | Prolonged miniature endplate currents | 2.00e-04 | 4 | 30 | 2 | HP:0003436 | |
| HumanPheno | Neck muscle weakness | 2.00e-04 | 95 | 30 | 5 | HP:0000467 | |
| HumanPheno | Pelvic girdle muscle weakness | 2.02e-04 | 51 | 30 | 4 | HP:0003749 | |
| HumanPheno | EMG abnormality | 2.09e-04 | 293 | 30 | 8 | HP:0003457 | |
| HumanPheno | Cystic hygroma | 2.18e-04 | 52 | 30 | 4 | HP:0000476 | |
| HumanPheno | Abnormal morphology of the pelvis musculature | 2.18e-04 | 52 | 30 | 4 | HP:0001469 | |
| HumanPheno | Abnormality of the hip-girdle musculature | 2.18e-04 | 52 | 30 | 4 | HP:0001445 | |
| HumanPheno | Hypoplastic heart | 2.52e-04 | 54 | 30 | 4 | HP:0001961 | |
| HumanPheno | Abnormal cervical spine morphology | 2.63e-04 | 22 | 30 | 3 | HP:0046508 | |
| HumanPheno | Limb-girdle muscle weakness | 2.92e-04 | 103 | 30 | 5 | HP:0003325 | |
| HumanPheno | Shoulder girdle muscle weakness | 3.11e-04 | 57 | 30 | 4 | HP:0003547 | |
| HumanPheno | Fatigable weakness of respiratory muscles | 3.33e-04 | 58 | 30 | 4 | HP:0030196 | |
| HumanPheno | Orthopnea | 3.65e-04 | 108 | 30 | 5 | HP:0012764 | |
| HumanPheno | Thoracic scoliosis | 3.79e-04 | 60 | 30 | 4 | HP:0002943 | |
| HumanPheno | Restrictive ventilatory defect | 3.97e-04 | 110 | 30 | 5 | HP:0002091 | |
| HumanPheno | Abnormal morphology of the musculature of the neck | 3.98e-04 | 171 | 30 | 6 | HP:0011006 | |
| HumanPheno | Abnormal cry | 4.04e-04 | 61 | 30 | 4 | HP:0025429 | |
| HumanPheno | Malignant hyperthermia | 4.37e-04 | 26 | 30 | 3 | HP:0002047 | |
| HumanPheno | Autoimmune antibody positivity | 4.51e-04 | 175 | 30 | 6 | HP:0030057 | |
| HumanPheno | Cyanosis | 5.28e-04 | 117 | 30 | 5 | HP:0000961 | |
| HumanPheno | Type 1 muscle fiber predominance | 5.47e-04 | 66 | 30 | 4 | HP:0003803 | |
| HumanPheno | Hyperreflexia in upper limbs | 5.47e-04 | 28 | 30 | 3 | HP:0007350 | |
| HumanPheno | Abnormal heart morphology | 5.89e-04 | 184 | 30 | 6 | HP:3000001 | |
| HumanPheno | Fatigable weakness | 6.16e-04 | 121 | 30 | 5 | HP:0003473 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 6.40e-04 | 122 | 30 | 5 | HP:0003398 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 6.40e-04 | 122 | 30 | 5 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission | 6.40e-04 | 122 | 30 | 5 | HP:0012535 | |
| HumanPheno | Ophthalmoplegia | 6.90e-04 | 265 | 30 | 7 | HP:0000602 | |
| HumanPheno | Ophthalmoparesis | 7.02e-04 | 350 | 30 | 8 | HP:0000597 | |
| HumanPheno | Abnormality of the musculature of the hand | 7.15e-04 | 125 | 30 | 5 | HP:0001421 | |
| HumanPheno | Weakness of facial musculature | 7.55e-04 | 269 | 30 | 7 | HP:0030319 | |
| HumanPheno | EMG: myopathic abnormalities | 8.26e-04 | 129 | 30 | 5 | HP:0003458 | |
| HumanPheno | Neonatal hypotonia | 9.65e-04 | 202 | 30 | 6 | HP:0001319 | |
| HumanPheno | Fetal akinesia sequence | 9.75e-04 | 34 | 30 | 3 | HP:0001989 | |
| HumanPheno | Arthrogryposis multiplex congenita | 1.27e-03 | 142 | 30 | 5 | HP:0002804 | |
| HumanPheno | Abnormal muscle fiber-type distribution | 1.30e-03 | 83 | 30 | 4 | HP:0033684 | |
| HumanPheno | Exertional dyspnea | 1.49e-03 | 147 | 30 | 5 | HP:0002875 | |
| HumanPheno | Abnormal muscle fiber morphology | 1.50e-03 | 302 | 30 | 7 | HP:0004303 | |
| HumanPheno | Akinesia | 1.57e-03 | 40 | 30 | 3 | HP:0002304 | |
| HumanPheno | Upper limb muscle weakness | 1.68e-03 | 151 | 30 | 5 | HP:0003484 | |
| HumanPheno | Poor suck | 1.73e-03 | 152 | 30 | 5 | HP:0002033 | |
| HumanPheno | Bulbar palsy | 1.81e-03 | 42 | 30 | 3 | HP:0001283 | |
| HumanPheno | Proximal hyperreflexia | 1.81e-03 | 42 | 30 | 3 | HP:0007054 | |
| HumanPheno | Lower limb hyperreflexia | 1.91e-03 | 92 | 30 | 4 | HP:0002395 | |
| MousePheno | abnormal miniature endplate potential | 7.93e-06 | 26 | 70 | 4 | MP:0004835 | |
| MousePheno | abnormal depression-related behavior | 1.25e-05 | 156 | 70 | 7 | MP:0003360 | |
| MousePheno | abnormal PNS synaptic transmission | 2.68e-05 | 35 | 70 | 4 | MP:0002913 | |
| MousePheno | abnormal pain threshold | 5.41e-05 | 267 | 70 | 8 | MP:0001970 | |
| MousePheno | abnormal synaptic transmission | SLC12A6 EPS8L2 FZD3 GPR37 SLC5A7 ABCC9 SLC44A4 CHRNA1 CHRNA2 CHRNB1 CHRNE OPRK1 CHRNG SLC12A5 KCNG1 CLMN | 5.96e-05 | 1070 | 70 | 16 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | SLC12A6 EPS8L2 FZD3 GPR37 SLC5A7 ABCC9 SLC44A4 CHRNA1 CHRNA2 CHRNB1 CHRNE OPRK1 CHRNG SLC12A5 KCNG1 CLMN | 6.37e-05 | 1076 | 70 | 16 | MP:0021009 |
| MousePheno | abnormal touch/ nociception | 1.02e-04 | 376 | 70 | 9 | MP:0001968 | |
| MousePheno | enhanced learning | 1.10e-04 | 19 | 70 | 3 | MP:0012314 | |
| MousePheno | abnormal neuromuscular synapse morphology | 1.11e-04 | 95 | 70 | 5 | MP:0001053 | |
| MousePheno | abnormal synapse morphology | 1.26e-04 | 224 | 70 | 7 | MP:0009538 | |
| MousePheno | abnormal somatic motor system morphology | 1.29e-04 | 98 | 70 | 5 | MP:0001051 | |
| MousePheno | analgesia | 1.47e-04 | 4 | 70 | 2 | MP:0004270 | |
| MousePheno | abnormal behavioral response to xenobiotic | 1.49e-04 | 309 | 70 | 8 | MP:0009745 | |
| MousePheno | abnormal tail hair pigmentation | 2.45e-04 | 5 | 70 | 2 | MP:0009933 | |
| MousePheno | enhanced avoidance learning behavior | 2.45e-04 | 5 | 70 | 2 | MP:0012313 | |
| MousePheno | enhanced passive avoidance behavior | 2.45e-04 | 5 | 70 | 2 | MP:0003999 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 GPR4 NPY5R OR9G1 LPAR5 GPR26 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 9.45e-19 | 691 | 98 | 29 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 GPR4 NPY5R OR9G1 LPAR5 GPR26 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 9.83e-19 | 692 | 98 | 29 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 GPR4 NPY5R OR9G1 LPAR5 GPR26 OR5D18 GPR37 GPR82 MC1R OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 TAS2R7 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 4.76e-18 | 670 | 98 | 28 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 GPR4 NPY5R OR9G1 LPAR5 GPR26 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 6.24e-18 | 677 | 98 | 28 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 GPR4 NPY5R OR9G1 LPAR5 GPR26 OR5D18 GPR37 GPR82 MC1R OR1F12P OR1A2 GPR183 SSTR3 OR9G9 OPRD1 OPRK1 OR10G4 OR13D1 OXTR GPR174 P2RY2 OR1A1 OR51V1 OR51B2 HCRTR1 HCRTR2 | 8.47e-18 | 685 | 98 | 28 | PS00237 |
| Domain | Nicotinic_acetylcholine_rcpt | 9.69e-13 | 16 | 98 | 7 | IPR002394 | |
| Domain | Acetylcholine_rcpt_TM | 2.02e-11 | 23 | 98 | 7 | IPR027361 | |
| Domain | - | 2.02e-11 | 23 | 98 | 7 | 1.20.120.370 | |
| Domain | 7TM_GPCR_Srsx | OR51A4 OR51A2 NPY5R MC1R GPR183 SSTR3 OPRD1 OPRK1 HCRTR1 HCRTR2 | 3.60e-10 | 112 | 98 | 10 | SM01381 |
| Domain | Neurotransmitter_ion_chnl_CS | 3.40e-09 | 45 | 98 | 7 | IPR018000 | |
| Domain | Neur_chan_memb | 3.99e-09 | 46 | 98 | 7 | PF02932 | |
| Domain | Neur_chan_LBD | 4.67e-09 | 47 | 98 | 7 | PF02931 | |
| Domain | Neur_channel | 4.67e-09 | 47 | 98 | 7 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.67e-09 | 47 | 98 | 7 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 4.67e-09 | 47 | 98 | 7 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 4.67e-09 | 47 | 98 | 7 | IPR006029 | |
| Domain | - | 4.67e-09 | 47 | 98 | 7 | 2.70.170.10 | |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 1.01e-06 | 393 | 98 | 12 | IPR000725 |
| Domain | Orexin_rcpt | 2.73e-05 | 2 | 98 | 2 | IPR000204 | |
| Domain | Sulphorea_rcpt | 2.73e-05 | 2 | 98 | 2 | IPR000388 | |
| Domain | PRT_C | 2.73e-05 | 2 | 98 | 2 | PF08372 | |
| Domain | PRibTrfase_C | 2.73e-05 | 2 | 98 | 2 | IPR013583 | |
| Domain | ABC_transporter_CS | 6.85e-05 | 42 | 98 | 4 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 1.16e-04 | 48 | 98 | 4 | PS50893 | |
| Domain | ABC_tran | 1.16e-04 | 48 | 98 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 1.26e-04 | 49 | 98 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.36e-04 | 50 | 98 | 4 | IPR003439 | |
| Domain | Pecanex_C | 1.62e-04 | 4 | 98 | 2 | PF05041 | |
| Domain | Opioid_rcpt | 1.62e-04 | 4 | 98 | 2 | IPR001418 | |
| Domain | Pecanex | 1.62e-04 | 4 | 98 | 2 | IPR007735 | |
| Domain | KCL_cotranspt | 1.62e-04 | 4 | 98 | 2 | IPR000076 | |
| Domain | AA-permease/SLC12A_dom | 2.01e-04 | 22 | 98 | 3 | IPR004841 | |
| Domain | AA_permease | 2.01e-04 | 22 | 98 | 3 | PF00324 | |
| Domain | Choline_transpo | 2.70e-04 | 5 | 98 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 2.70e-04 | 5 | 98 | 2 | IPR007603 | |
| Domain | K_chnl_volt-dep_Kv | 3.74e-04 | 27 | 98 | 3 | IPR003968 | |
| Domain | Mg_trans_NIPA | 4.03e-04 | 6 | 98 | 2 | IPR008521 | |
| Domain | Mg_trans_NIPA | 4.03e-04 | 6 | 98 | 2 | PF05653 | |
| Domain | SLC12A_fam | 5.63e-04 | 7 | 98 | 2 | IPR004842 | |
| Domain | VG_K_chnl | 6.82e-04 | 33 | 98 | 3 | IPR028325 | |
| Domain | SLC12 | 7.48e-04 | 8 | 98 | 2 | PF03522 | |
| Domain | SLC12_C | 7.48e-04 | 8 | 98 | 2 | IPR018491 | |
| Domain | ABC_A | 1.74e-03 | 12 | 98 | 2 | IPR026082 | |
| Domain | BTB_2 | 2.71e-03 | 53 | 98 | 3 | PF02214 | |
| Domain | T1-type_BTB | 2.71e-03 | 53 | 98 | 3 | IPR003131 | |
| Domain | Channel_four-helix_dom | 3.34e-03 | 57 | 98 | 3 | IPR027359 | |
| Domain | - | 3.34e-03 | 57 | 98 | 3 | 1.20.120.350 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.95e-03 | 18 | 98 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.40e-03 | 19 | 98 | 2 | PS50267 | |
| Domain | SNF | 4.40e-03 | 19 | 98 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 4.40e-03 | 19 | 98 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.40e-03 | 19 | 98 | 2 | PS00610 | |
| Domain | GroES-like | 6.98e-03 | 24 | 98 | 2 | IPR011032 | |
| Domain | ABC_membrane | 6.98e-03 | 24 | 98 | 2 | PF00664 | |
| Domain | AAA+_ATPase | 7.00e-03 | 144 | 98 | 4 | IPR003593 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR4 NPY6R NPY5R LPAR5 GPR37 MC1R OR1A2 SSTR3 OPRD1 OPRK1 OXTR GPR174 P2RY2 OR1A1 HCRTR1 HCRTR2 | 5.66e-13 | 260 | 77 | 16 | M39397 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | NPY5R MC1R SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG OXTR P2RY2 HCRTR1 HCRTR2 | 1.13e-12 | 272 | 77 | 16 | M13380 |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.96e-11 | 12 | 77 | 6 | M48008 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 6.32e-11 | 14 | 77 | 6 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.05e-10 | 15 | 77 | 6 | MM14704 | |
| Pathway | WP_GPCRS_NONODORANT | NPY6R NPY5R LPAR5 FZD3 MC1R SSTR3 OPRD1 OPRK1 TAS2R7 OXTR GPR174 P2RY2 HCRTR1 HCRTR2 | 1.50e-10 | 266 | 77 | 14 | MM15843 |
| Pathway | WP_PEPTIDE_GPCRS | 2.51e-10 | 75 | 77 | 9 | M39696 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GPR4 NPY5R LPAR5 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 OXTR P2RY2 HCRTR1 HCRTR2 | 2.39e-08 | 330 | 77 | 13 | M18334 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPR4 NPY5R LPAR5 FZD3 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 TAS2R7 OXTR P2RY2 HCRTR1 HCRTR2 | 2.42e-08 | 463 | 77 | 15 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | GPR4 NPY5R LPAR5 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 OXTR P2RY2 HCRTR1 HCRTR2 | 2.66e-08 | 333 | 77 | 13 | MM14963 |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 2.84e-08 | 7 | 77 | 4 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 2.84e-08 | 7 | 77 | 4 | MM15311 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | GPR4 NPY5R LPAR5 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 TAS2R7 OXTR P2RY2 HCRTR1 HCRTR2 | 7.11e-08 | 430 | 77 | 14 | MM15160 |
| Pathway | WP_GPCRS_PEPTIDE | 1.00e-07 | 70 | 77 | 7 | MM15959 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | KCNV2 SLC5A7 ABCC9 CHRNA1 CHRNA2 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 | 2.45e-07 | 335 | 77 | 12 | MM14503 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 7.44e-07 | 186 | 77 | 9 | MM15994 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPR4 NPY5R LPAR5 FZD3 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 TAS2R7 OXTR P2RY2 ABHD12 HCRTR1 HCRTR2 | 9.57e-07 | 702 | 77 | 16 | M746 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.20e-06 | 197 | 77 | 9 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 1.20e-06 | 197 | 77 | 9 | MM14970 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | GPR4 NPY5R LPAR5 GPR37 MC1R GPR183 SSTR3 OPRD1 OPRK1 TAS2R7 OXTR P2RY2 ABHD12 HCRTR1 HCRTR2 | 1.76e-06 | 646 | 77 | 15 | MM14962 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ATP13A4 ATP8B4 SLC5A7 ABCC9 SLC6A15 ANO10 SLC44A4 ABCA7 ABCA10 SLC12A5 ESYT3 SLC44A5 SLC26A7 NIPAL2 NIPA1 | 1.78e-06 | 736 | 77 | 16 | M27287 |
| Pathway | REACTOME_NEURONAL_SYSTEM | KCNV2 SLC5A7 ABCC9 CHRNA1 CHRNA2 CHRNB4 CHRND CHRNE CHRNG KCNC3 KCNG1 ABCC8 | 2.13e-06 | 411 | 77 | 12 | M735 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 2.47e-06 | 417 | 77 | 12 | M4072 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ATP13A4 ATP8B4 SLC5A7 ABCC9 SLC6A15 ANO10 SLC44A4 ABCA7 SLC12A5 ESYT3 SLC44A5 SLC26A7 NIPAL2 NIPA1 | 3.37e-06 | 681 | 77 | 15 | MM14985 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 EPS8L2 OR9G1 OR5D18 OR1F12P OR1A2 OR9G9 OR10G4 TAS2R7 OR13D1 OR1A1 OR51V1 OR51B2 | 7.56e-06 | 636 | 77 | 14 | M41834 |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.29e-05 | 9 | 77 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.29e-05 | 9 | 77 | 3 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.51e-05 | 11 | 77 | 3 | M883 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.33e-05 | 12 | 77 | 3 | MM15312 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR9G1 OR5D18 OR1A2 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 4.81e-05 | 389 | 77 | 10 | M14091 |
| Pathway | KEGG_ABC_TRANSPORTERS | 9.46e-05 | 44 | 77 | 4 | M11911 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.34e-04 | 144 | 77 | 6 | MM14501 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.47e-04 | 210 | 77 | 7 | MM15043 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.51e-04 | 211 | 77 | 7 | MM14502 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.75e-04 | 289 | 77 | 8 | MM15057 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.79e-04 | 217 | 77 | 7 | M18437 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 1.95e-04 | 98 | 77 | 5 | MM14545 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 2.46e-04 | 103 | 77 | 5 | M1073 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.07e-04 | 314 | 77 | 8 | M600 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 3.15e-04 | 238 | 77 | 7 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.14e-04 | 249 | 77 | 7 | M5988 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 5.74e-04 | 70 | 77 | 4 | MM14984 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.08e-04 | 7 | 77 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.08e-04 | 7 | 77 | 2 | MM15081 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.71e-04 | 270 | 77 | 7 | M15514 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 7.84e-04 | 76 | 77 | 4 | MM15072 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 8.07e-04 | 8 | 77 | 2 | M27291 | |
| Pathway | REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS | 8.07e-04 | 8 | 77 | 2 | MM14995 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.84e-04 | 205 | 77 | 6 | M752 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 1.14e-03 | 84 | 77 | 4 | M27334 | |
| Pathway | WP_SLEEP_REGULATION | 1.15e-03 | 38 | 77 | 3 | M39504 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.44e-03 | 41 | 77 | 3 | MM14546 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.65e-03 | 43 | 77 | 3 | M1056 | |
| Pathway | WP_GPCRS_ODORANT | 1.67e-03 | 157 | 77 | 5 | MM15872 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.57e-03 | 14 | 77 | 2 | M16884 | |
| Pathway | BIOCARTA_ACH_PATHWAY | 2.57e-03 | 14 | 77 | 2 | MM1485 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.87e-03 | 108 | 77 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.97e-03 | 109 | 77 | 4 | MM15074 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 3.81e-03 | 190 | 77 | 5 | MM15687 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 4.26e-03 | 18 | 77 | 2 | M524 | |
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 7.71e-15 | 15 | 99 | 7 | 8838678 | |
| Pubmed | 1.37e-14 | 16 | 99 | 7 | 19259974 | ||
| Pubmed | Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells. | 1.69e-13 | 5 | 99 | 5 | 2383398 | |
| Pubmed | NPY5R SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG OXTR HCRTR1 HCRTR2 | 1.84e-13 | 300 | 99 | 14 | 19086053 | |
| Pubmed | 1.34e-12 | 14 | 99 | 6 | 19059502 | ||
| Pubmed | Acetylcholine receptor gene expression at the developing neuromuscular junction. | 6.18e-11 | 4 | 99 | 4 | 7724666 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 23519471 | ||
| Pubmed | Design and control of acetylcholine receptor conformational change. | 6.18e-11 | 4 | 99 | 4 | 21368211 | |
| Pubmed | Developmental changes in the nicotinic acetylcholine receptor in mouse tongue striated muscle. | 6.18e-11 | 4 | 99 | 4 | 11926244 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 21480901 | ||
| Pubmed | Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially. | 6.18e-11 | 4 | 99 | 4 | 8334706 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 19422391 | ||
| Pubmed | Ceramides modulate cell-surface acetylcholine receptor levels. | 6.18e-11 | 4 | 99 | 4 | 18023270 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 22474383 | ||
| Pubmed | Regulation of nicotinic receptor expression by the ubiquitin-proteasome system. | 6.18e-11 | 4 | 99 | 4 | 15483627 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 8872460 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 15864502 | ||
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 4781450 | ||
| Pubmed | Refined structure of the nicotinic acetylcholine receptor at 4A resolution. | 6.18e-11 | 4 | 99 | 4 | 15701510 | |
| Pubmed | 6.18e-11 | 4 | 99 | 4 | 8955122 | ||
| Pubmed | 1.32e-10 | 12 | 99 | 5 | 20584212 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 18252226 | ||
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 8798466 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 CHRNG ABCC8 | 4.21e-10 | 275 | 99 | 11 | 20734064 |
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 9580980 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | AUP1 WFS1 GPR37 GDPD2 ANO10 ABCA7 SLC12A5 MFSD14A VAC14 BCAP31 OXTR ABCC8 NIPAL2 NIPA1 ABHD12 | 1.32e-09 | 697 | 99 | 15 | 28298427 |
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 22496563 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 18591429 | ||
| Pubmed | Motor and Sensory Deficits in the teetering Mice Result from Mutation of the ESCRT Component HGS. | 6.87e-09 | 24 | 99 | 5 | 26115514 | |
| Pubmed | 7.70e-09 | 9 | 99 | 4 | 8416841 | ||
| Pubmed | 1.06e-08 | 26 | 99 | 5 | 20301347 | ||
| Pubmed | 1.28e-08 | 10 | 99 | 4 | 12388596 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 19171769 | ||
| Pubmed | Intersubunit contacts governing assembly of the mammalian nicotinic acetylcholine receptor. | 2.24e-08 | 3 | 99 | 3 | 7695910 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 2221824 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 18625075 | ||
| Pubmed | The acetylcholine receptor gamma-to-epsilon switch occurs in individual endplates. | 2.24e-08 | 3 | 99 | 3 | 15883046 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 23448903 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 3782129 | ||
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 12012784 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 19307444 | ||
| Pubmed | 8.93e-08 | 4 | 99 | 3 | 18179903 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.07e-07 | 79 | 99 | 6 | 12679517 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 2.32e-07 | 19 | 99 | 4 | 17373692 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR9G1 OR5D18 OR1F12P OR1A2 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 5.87e-07 | 340 | 99 | 9 | 11875048 |
| Pubmed | OR9G1 OR5D18 OR1F12P OR1A2 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 5.87e-07 | 340 | 99 | 9 | 11802173 | |
| Pubmed | OR9G1 OR5D18 OR1F12P OR1A2 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 6.31e-07 | 343 | 99 | 9 | 32295537 | |
| Pubmed | OR9G1 OR5D18 OR1F12P OR1A2 OR10G4 OR13D1 OR1A1 OR51V1 OR51B2 | 6.79e-07 | 346 | 99 | 9 | 14611657 | |
| Pubmed | 7.77e-07 | 7 | 99 | 3 | 16407563 | ||
| Pubmed | Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. | 7.77e-07 | 7 | 99 | 3 | 8393145 | |
| Pubmed | Chromosomal localization of muscle nicotinic acetylcholine receptor genes in the mouse. | 7.77e-07 | 7 | 99 | 3 | 3022377 | |
| Pubmed | Essential roles of the acetylcholine receptor gamma-subunit in neuromuscular synaptic patterning. | 1.24e-06 | 8 | 99 | 3 | 18434415 | |
| Pubmed | Aberrant development of motor axons and neuromuscular synapses in MyoD-null mice. | 1.24e-06 | 8 | 99 | 3 | 12832540 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.87e-06 | 128 | 99 | 6 | 19058789 | |
| Pubmed | QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. | 2.65e-06 | 10 | 99 | 3 | 12118100 | |
| Pubmed | 2.65e-06 | 10 | 99 | 3 | 20736995 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 7.98e-06 | 95 | 99 | 5 | 16754659 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 3244354 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 19171937 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22844491 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16331961 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 34475397 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21510948 | ||
| Pubmed | Neurotransmitter transporters in the central nervous system. | 8.02e-06 | 2 | 99 | 2 | 10471414 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27237973 | ||
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 8.02e-06 | 2 | 99 | 2 | 7649271 | |
| Pubmed | Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. | 8.02e-06 | 2 | 99 | 2 | 26950369 | |
| Pubmed | Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. | 8.02e-06 | 2 | 99 | 2 | 11723285 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26181369 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22389503 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 8910344 | ||
| Pubmed | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. | 8.02e-06 | 2 | 99 | 2 | 24923251 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11112352 | ||
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 8.02e-06 | 2 | 99 | 2 | 8393575 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24278116 | ||
| Pubmed | Cellular localization of orexin receptors in human pituitary. | 8.02e-06 | 2 | 99 | 2 | 11443222 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 7688301 | ||
| Pubmed | Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. | 8.02e-06 | 2 | 99 | 2 | 24485472 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 7531341 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 2708381 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11316510 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15528213 | ||
| Pubmed | G-protein-coupled receptor heterodimerization modulates receptor function. | 8.02e-06 | 2 | 99 | 2 | 10385123 | |
| Pubmed | Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. | 8.02e-06 | 2 | 99 | 2 | 8910290 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 24240098 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27052180 | ||
| Pubmed | Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice. | 8.02e-06 | 2 | 99 | 2 | 33529173 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15256537 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 27375219 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 15797953 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17622222 | ||
| Pubmed | Peripherally administered orexin improves survival of mice with endotoxin shock. | 8.02e-06 | 2 | 99 | 2 | 28035899 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16826524 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16826520 | ||
| Pubmed | Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". | 8.02e-06 | 2 | 99 | 2 | 26582896 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 38199807 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 8662820 | ||
| Pubmed | Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. | 8.02e-06 | 2 | 99 | 2 | 21377495 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 7902325 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16712978 | ||
| Interaction | TTYH1 interactions | SLC12A6 PCNX3 GPR37 ANO10 SSTR3 ABCA7 SLC44A5 DPY19L4 ABHD12 | 8.57e-06 | 300 | 91 | 9 | int:TTYH1 |
| Interaction | SEC62 interactions | SLC12A6 AUP1 WFS1 SLC6A15 GPR183 ANO10 BCAP31 CLMN VKORC1L1 LPGAT1 ABHD12 | 1.73e-05 | 506 | 91 | 11 | int:SEC62 |
| Interaction | OPRK1 interactions | 3.13e-05 | 14 | 91 | 3 | int:OPRK1 | |
| Interaction | CHRNA1 interactions | 5.98e-05 | 47 | 91 | 4 | int:CHRNA1 | |
| Interaction | CHRNA2 interactions | 6.03e-05 | 3 | 91 | 2 | int:CHRNA2 | |
| Interaction | WLS interactions | 6.38e-05 | 93 | 91 | 5 | int:WLS | |
| Interaction | OR2G6 interactions | 6.92e-05 | 18 | 91 | 3 | int:OR2G6 | |
| Interaction | TMEM63A interactions | 1.04e-04 | 103 | 91 | 5 | int:TMEM63A | |
| Interaction | SYVN1 interactions | 1.09e-04 | 324 | 91 | 8 | int:SYVN1 | |
| Interaction | SLC17A2 interactions | 1.19e-04 | 56 | 91 | 4 | int:SLC17A2 | |
| Interaction | CNNM1 interactions | 1.19e-04 | 56 | 91 | 4 | int:CNNM1 | |
| Interaction | ATP2A1 interactions | 1.25e-04 | 423 | 91 | 9 | int:ATP2A1 | |
| Interaction | CANX interactions | SLC12A6 AUP1 WFS1 HS6ST2 SLC6A15 CHRNA1 CHRNB1 CHRND OPRD1 BCAP31 SLC44A5 AMIGO3 CLMN DPY19L4 LPGAT1 ABHD12 | 1.52e-04 | 1261 | 91 | 16 | int:CANX |
| Interaction | EDA interactions | 1.61e-04 | 113 | 91 | 5 | int:EDA | |
| Interaction | TPST2 interactions | 2.48e-04 | 124 | 91 | 5 | int:TPST2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 3.17e-05 | 564 | 99 | 8 | chr11p15 | |
| Cytoband | 15q13 | 1.64e-04 | 9 | 99 | 2 | 15q13 | |
| Cytoband | 8p21 | 8.53e-04 | 20 | 99 | 2 | 8p21 | |
| Cytoband | 11p15.4 | 9.52e-04 | 200 | 99 | 4 | 11p15.4 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.60e-13 | 16 | 74 | 7 | 173 | |
| GeneFamily | Solute carriers | SLC12A6 SLC7A13 SLC6A16 SLC5A7 SLC6A15 SLC44A4 SLCO6A1 SLC12A5 SLC44A5 SLC26A7 SLC22A13 | 5.73e-07 | 395 | 74 | 11 | 752 |
| GeneFamily | G protein-coupled receptors, Class A orphans | 7.78e-07 | 78 | 74 | 6 | 262 | |
| GeneFamily | Hypocretin receptors | 1.65e-05 | 2 | 74 | 2 | 228 | |
| GeneFamily | Multiple C2 and transmembrane domain containing | 1.65e-05 | 2 | 74 | 2 | 826 | |
| GeneFamily | Olfactory receptors, family 51 | 3.10e-05 | 44 | 74 | 4 | 164 | |
| GeneFamily | Opioid receptors | 9.86e-05 | 4 | 74 | 2 | 245 | |
| GeneFamily | Potassium voltage-gated channels | 5.83e-04 | 40 | 74 | 3 | 274 | |
| GeneFamily | Olfactory receptors, family 1 | 5.83e-04 | 40 | 74 | 3 | 147 | |
| GeneFamily | Neuropeptide receptors | 7.28e-04 | 10 | 74 | 2 | 854 | |
| GeneFamily | ATP binding cassette subfamily C | 1.25e-03 | 13 | 74 | 2 | 807 | |
| GeneFamily | ATP binding cassette subfamily A | 1.46e-03 | 14 | 74 | 2 | 805 | |
| GeneFamily | Olfactory receptors, family 9 | 3.95e-03 | 23 | 74 | 2 | 156 | |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN | 7.32e-06 | 124 | 98 | 6 | M470 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-06 | 171 | 97 | 6 | fa5cc720bd0045d0307439be547b41d56def5b43 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 184 | 97 | 6 | ca940a4f4970285ed284d5517d142abab0682044 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.65e-06 | 189 | 97 | 6 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 196 | 97 | 6 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-05 | 137 | 97 | 5 | 0c82f815c014d01213d23b466043d6e57186dceb | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-05 | 147 | 97 | 5 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.82e-05 | 148 | 97 | 5 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.82e-05 | 148 | 97 | 5 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 155 | 97 | 5 | 7a16df1a40c7255c24dfb9a921b62871554c7b6d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 155 | 97 | 5 | f51a12556ca0a3416a6cf0687f908fb4e752fb2f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 159 | 97 | 5 | 32d4c9f7ba6a96ce8443396b80568b41cbfc4927 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 162 | 97 | 5 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.89e-05 | 163 | 97 | 5 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 168 | 97 | 5 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-05 | 168 | 97 | 5 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-05 | 171 | 97 | 5 | fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.84e-05 | 173 | 97 | 5 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-05 | 173 | 97 | 5 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.64e-05 | 180 | 97 | 5 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.76e-05 | 181 | 97 | 5 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-05 | 184 | 97 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-05 | 184 | 97 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.28e-05 | 185 | 97 | 5 | 405bd4ba7ca7f7b625c49f1313ff946509e17c13 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.28e-05 | 185 | 97 | 5 | 2aa5e9f6f167d27317a01d22392b59512333fa64 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-05 | 186 | 97 | 5 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 187 | 97 | 5 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-05 | 187 | 97 | 5 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.70e-05 | 188 | 97 | 5 | f4d11d06be46f13adbf36d94bc2bdcd14d0bfa75 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 189 | 97 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.99e-05 | 190 | 97 | 5 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.15e-05 | 191 | 97 | 5 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.15e-05 | 191 | 97 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.46e-05 | 193 | 97 | 5 | 2684fa361baaa9dc7a18a39ed11c0759e78e4418 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 97 | 5 | a062100ea6cd512a108f9036c259e0cd0f458563 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 194 | 97 | 5 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 97 | 5 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 195 | 97 | 5 | 799992721369357484300fe218aff075154c3148 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.94e-05 | 196 | 97 | 5 | b2aee2f67da373a10b0c25e7797e30e3811543a8 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 6.94e-05 | 196 | 97 | 5 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 6.94e-05 | 196 | 97 | 5 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.11e-05 | 197 | 97 | 5 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 7.28e-05 | 198 | 97 | 5 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.46e-05 | 199 | 97 | 5 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK_CD56bright|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.64e-05 | 200 | 97 | 5 | d06bea5b4af9559a517e769a373b873cd7bdcb48 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-04 | 113 | 97 | 4 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-04 | 126 | 97 | 4 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Grem_(Globus_Pallidus_Externus_(GP),_Lhx6-enriched)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 49 | 97 | 3 | bbbffec51d6ac73ddd33d8d85354fb830e274270 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Grem_(Globus_Pallidus_Externus_(GP),_Lhx6-enriched)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 49 | 97 | 3 | f8c2b72e155f406e3a59072594ad092b6c5ff200 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Grem_(Globus_Pallidus_Externus_(GP),_Lhx6-enriched)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 49 | 97 | 3 | 1acddd787e05bae150909890cfdf966806881260 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 128 | 97 | 4 | e100629f6038e32176ffcc81bd06bd175df46cef | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-04 | 137 | 97 | 4 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-04 | 137 | 97 | 4 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 141 | 97 | 4 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 141 | 97 | 4 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-04 | 144 | 97 | 4 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-04 | 144 | 97 | 4 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.77e-04 | 144 | 97 | 4 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.77e-04 | 144 | 97 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-04 | 145 | 97 | 4 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.84e-04 | 145 | 97 | 4 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.84e-04 | 145 | 97 | 4 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.15e-04 | 149 | 97 | 4 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 3.23e-04 | 150 | 97 | 4 | 0a65f5e2f4e0b0e822b029e0222b28ba2db89e6d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-04 | 153 | 97 | 4 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 3.57e-04 | 154 | 97 | 4 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-04 | 157 | 97 | 4 | ad8c6eb34f5288288c4066119c17325afefbaafc | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.85e-04 | 65 | 97 | 3 | c736a773a1b9cb16b51849a3bf0ccd9aeec7b342 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.85e-04 | 65 | 97 | 3 | 8f7eac868f1605830cc97d9d1676f3ebff47d49b | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.85e-04 | 65 | 97 | 3 | 350f33bcc5924d7e3c3318391d33a984763fe206 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.85e-04 | 65 | 97 | 3 | f14b28214f80ed23501ab28ff254c206f70d77b2 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 66 | 97 | 3 | d5e878ffc0b942a35391c7dd73b30cec59f21b39 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 66 | 97 | 3 | fdb695bbda639112c2f7b714adb7501aef4be19e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.03e-04 | 66 | 97 | 3 | de909119de42711b6580274b1200c0e1c6ad2f55 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-04 | 161 | 97 | 4 | a14773afbe0e64662bfa5fce793cd9d05c24a9b5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.23e-04 | 161 | 97 | 4 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | severe-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.23e-04 | 161 | 97 | 4 | 9e8e8ac11f7fb8c8697357c21034b613f191db2b | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.32e-04 | 162 | 97 | 4 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 4.32e-04 | 162 | 97 | 4 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 164 | 97 | 4 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 165 | 97 | 4 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 165 | 97 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 165 | 97 | 4 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-04 | 165 | 97 | 4 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.63e-04 | 165 | 97 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-04 | 166 | 97 | 4 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 97 | 4 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 97 | 4 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 97 | 4 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 97 | 4 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 97 | 4 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | CTRL-Myeloid-Monocyte|CTRL / Disease state, Lineage and Cell class | 4.96e-04 | 168 | 97 | 4 | 13dca90c7b811e4d5e8fa44f5e892e29be9787a6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 168 | 97 | 4 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.96e-04 | 168 | 97 | 4 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 168 | 97 | 4 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-04 | 168 | 97 | 4 | 99343f7a76ff70a2252c365d527f9c8ae16b8571 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.96e-04 | 168 | 97 | 4 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.96e-04 | 168 | 97 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.07e-04 | 169 | 97 | 4 | 45ac692a0c9064ce6b6a31c2cd21c85ccf594670 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-04 | 169 | 97 | 4 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| Computational | Genes in the cancer module 146. | 1.50e-10 | 102 | 42 | 9 | MODULE_146 | |
| Computational | Ion channels. | 3.31e-06 | 27 | 42 | 4 | MODULE_214 | |
| Computational | Genes in the cancer module 134. | 5.13e-06 | 30 | 42 | 4 | MODULE_134 | |
| Computational | Ion channels. | 7.15e-06 | 70 | 42 | 5 | MODULE_316 | |
| Computational | Genes in the cancer module 27. | 7.18e-06 | 355 | 42 | 9 | MODULE_27 | |
| Computational | Genes in the cancer module 288. | 1.21e-05 | 37 | 42 | 4 | MODULE_288 | |
| Computational | Vesicular transport / synapse genes. | 1.56e-05 | 82 | 42 | 5 | MODULE_274 | |
| Computational | Membranal receptors. | PRPH2 GPR183 CHRNA2 CHRNB1 CHRNB4 CHRND CHRNE OPRK1 OXTR KCNC3 | 2.22e-05 | 517 | 42 | 10 | MODULE_64 |
| Computational | Genes in the cancer module 267. | 2.44e-05 | 15 | 42 | 3 | MODULE_267 | |
| Computational | Porins / transporters. | 1.55e-04 | 211 | 42 | 6 | MODULE_63 | |
| Computational | GPCR signaling pathways (immune and neuro). | 4.03e-04 | 90 | 42 | 4 | MODULE_375 | |
| Computational | Genes in the cancer module 287. | 9.57e-04 | 50 | 42 | 3 | MODULE_287 | |
| Computational | AcetylCholine receptors. | 1.32e-03 | 14 | 42 | 2 | MODULE_328 | |
| Computational | Genes in the cancer module 289. | 1.35e-03 | 124 | 42 | 4 | MODULE_289 | |
| Drug | poly-APS | 3.23e-10 | 4 | 98 | 4 | ctd:C115254 | |
| Drug | sulfoxaflor | 4.81e-09 | 6 | 98 | 4 | ctd:C560328 | |
| Drug | acetylcholine | SLC5A7 SLC44A4 CHRNA1 CHRNA2 CHRNB1 CHRNB4 CHRND OPRD1 CHRNE OPRK1 P2RY2 KCNG1 ABCC8 | 5.15e-09 | 361 | 98 | 13 | CID000000187 |
| Drug | Acetylcholine | 5.58e-09 | 91 | 98 | 8 | ctd:D000109 | |
| Drug | pozanicline | 4.00e-08 | 9 | 98 | 4 | ctd:C108326 | |
| Drug | Skpymrfamide | 4.22e-08 | 23 | 98 | 5 | CID000132661 | |
| Drug | hemicholinium-3 | 4.53e-08 | 78 | 98 | 7 | CID000003585 | |
| Drug | procyclidine | 5.31e-08 | 24 | 98 | 5 | CID000004919 | |
| Drug | neuroNal | 6.56e-08 | 49 | 98 | 6 | CID000010535 | |
| Drug | beta-eudesmol | 8.16e-08 | 26 | 98 | 5 | CID000091457 | |
| Drug | mecamylamine | 1.14e-07 | 89 | 98 | 7 | CID000004032 | |
| Drug | bifemelane | 1.46e-07 | 29 | 98 | 5 | CID000002377 | |
| Drug | tetrahydrodeoxycortisol | 2.07e-07 | 31 | 98 | 5 | CID000010593 | |
| Drug | tropicamide | 2.45e-07 | 32 | 98 | 5 | CID000005593 | |
| Drug | decamethonium | 2.87e-07 | 33 | 98 | 5 | CID000002968 | |
| Drug | cytisine | 2.87e-07 | 33 | 98 | 5 | CID000010235 | |
| Drug | LNF 209 | 3.13e-07 | 14 | 98 | 4 | CID000132666 | |
| Drug | Ultracet | 3.34e-07 | 64 | 98 | 6 | CID000005523 | |
| Drug | (+/-)-Epibatidine | 3.91e-07 | 35 | 98 | 5 | CID000001204 | |
| Drug | benzilate | 4.02e-07 | 66 | 98 | 6 | CID000201538 | |
| Drug | (-)-pictamine | 4.25e-07 | 15 | 98 | 4 | CID006918623 | |
| Drug | (-)-lepadin B | 4.25e-07 | 15 | 98 | 4 | CID006918624 | |
| Drug | UB-165 | 4.25e-07 | 15 | 98 | 4 | CID004694339 | |
| Drug | AC1L2SVN | 5.64e-07 | 16 | 98 | 4 | CID000127922 | |
| Drug | NSC-293162 | 5.98e-07 | 38 | 98 | 5 | CID000004675 | |
| Drug | benzetimide | 9.43e-07 | 18 | 98 | 4 | CID000021846 | |
| Drug | ABT-594 | 9.43e-07 | 18 | 98 | 4 | CID003075702 | |
| Drug | AC1LCVGE | 9.43e-07 | 18 | 98 | 4 | CID000656712 | |
| Drug | N-methylscopolamine | 9.99e-07 | 42 | 98 | 5 | CID000004120 | |
| Drug | gallamin | 1.13e-06 | 43 | 98 | 5 | CID000067425 | |
| Drug | AC1L9P88 | 1.19e-06 | 19 | 98 | 4 | CID000450860 | |
| Drug | isoarecolone | 1.19e-06 | 19 | 98 | 4 | CID000146970 | |
| Drug | beta-erythroidine | 1.19e-06 | 19 | 98 | 4 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 1.19e-06 | 19 | 98 | 4 | CID000107881 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.19e-06 | 19 | 98 | 4 | CID000162425 | |
| Drug | dihydro-beta-erythroidine | 1.27e-06 | 44 | 98 | 5 | CID000031762 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.48e-06 | 20 | 98 | 4 | CID000001962 | |
| Drug | ipratropium bromide | 1.59e-06 | 46 | 98 | 5 | CID000003746 | |
| Drug | pilsicainide | 1.59e-06 | 46 | 98 | 5 | CID000004820 | |
| Drug | dinotefuran | 1.83e-06 | 21 | 98 | 4 | CID000197701 | |
| Drug | meproadifen | 1.83e-06 | 21 | 98 | 4 | CID000189752 | |
| Drug | edrophonium | 1.97e-06 | 48 | 98 | 5 | CID000003202 | |
| Drug | suberyldicholine | 2.22e-06 | 22 | 98 | 4 | CID000123989 | |
| Drug | AR-R17779 | 2.22e-06 | 22 | 98 | 4 | CID005310971 | |
| Drug | histrionicotoxin | 2.22e-06 | 22 | 98 | 4 | CID005282247 | |
| Drug | clothianidin | 2.22e-06 | 22 | 98 | 4 | CID000213027 | |
| Drug | Substance P | NPY5R SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRND OPRD1 CHRNE OPRK1 KITLG | 2.29e-06 | 343 | 98 | 10 | CID000036511 |
| Drug | McN-A-343 | 2.42e-06 | 50 | 98 | 5 | CID000004022 | |
| Drug | AC1L3BL8 | 2.68e-06 | 23 | 98 | 4 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 2.68e-06 | 23 | 98 | 4 | CID000133011 | |
| Drug | CID6325740 | 2.68e-06 | 23 | 98 | 4 | CID006325740 | |
| Drug | ABT-418 | 2.68e-06 | 23 | 98 | 4 | CID000119380 | |
| Drug | alpha-conotoxin SI | 2.68e-06 | 23 | 98 | 4 | CID000163979 | |
| Drug | hexamethonium | 2.86e-06 | 143 | 98 | 7 | CID000003604 | |
| Drug | intruder | 3.21e-06 | 24 | 98 | 4 | CID000213021 | |
| Drug | anabaseine | 3.21e-06 | 24 | 98 | 4 | CID000018985 | |
| Drug | anabasine | 3.81e-06 | 25 | 98 | 4 | CID000002181 | |
| Drug | varenicline | 3.81e-06 | 25 | 98 | 4 | CID000170361 | |
| Drug | PrBCM | 3.81e-06 | 25 | 98 | 4 | CID000037396 | |
| Drug | AC1Q5SQW | 3.81e-06 | 25 | 98 | 4 | CID000003912 | |
| Drug | pempidine | 3.81e-06 | 25 | 98 | 4 | CID000006603 | |
| Drug | Bungarotoxins | 3.81e-06 | 25 | 98 | 4 | ctd:D002038 | |
| Drug | nefiracetam | 4.28e-06 | 56 | 98 | 5 | CID000071157 | |
| Drug | benzquinamide | 4.49e-06 | 26 | 98 | 4 | CID000002342 | |
| Drug | curarine | 4.49e-06 | 26 | 98 | 4 | CID000198004 | |
| Drug | NSC624746 | 4.67e-06 | 57 | 98 | 5 | CID000107640 | |
| Drug | methylcarbamylcholine | 5.25e-06 | 27 | 98 | 4 | CID000004136 | |
| Drug | nornicotine | 5.25e-06 | 27 | 98 | 4 | CID000000412 | |
| Drug | dimethylphenylpiperazinium | 5.55e-06 | 59 | 98 | 5 | CID000001316 | |
| Drug | echothiophate | 6.10e-06 | 28 | 98 | 4 | CID000010547 | |
| Drug | AC1NSM1F | 6.37e-06 | 9 | 98 | 3 | CID005312118 | |
| Drug | otenzepad | 6.55e-06 | 61 | 98 | 5 | CID000107867 | |
| Drug | bromoacetylcholine bromide | 7.06e-06 | 29 | 98 | 4 | CID000204966 | |
| Drug | NSC755875 | 7.35e-06 | 165 | 98 | 7 | CID000002215 | |
| Drug | methoctramine | 7.69e-06 | 63 | 98 | 5 | CID000004108 | |
| Drug | succinylcholine | 8.31e-06 | 64 | 98 | 5 | CID000005314 | |
| Drug | verapamil | KCNV2 ABCC9 ABCA7 ABCA10 CHRNA1 CHRNA2 CHRNB1 CHRND CHRNE KCNC3 KCNG1 | 8.52e-06 | 490 | 98 | 11 | CID000002520 |
| Drug | 4-DAMP | 8.97e-06 | 65 | 98 | 5 | CID000001734 | |
| Drug | AC1L1JK6 | 9.29e-06 | 31 | 98 | 4 | CID000005077 | |
| Drug | disopyramide | 9.68e-06 | 66 | 98 | 5 | CID000003114 | |
| Drug | phenoxybenzamine | 1.05e-05 | 115 | 98 | 6 | CID000004768 | |
| Drug | AC1NSKJI | 1.12e-05 | 68 | 98 | 5 | CID005311391 | |
| Drug | dopamine | SLC6A16 GPR37 KCNV2 PRPH2 SLC6A15 SSTR3 CHRNA1 CHRNA2 CHRNB1 CHRND OPRD1 CHRNE OPRK1 | 1.20e-05 | 715 | 98 | 13 | CID000000681 |
| Drug | methamidophos | 1.20e-05 | 33 | 98 | 4 | CID000004096 | |
| Drug | Neuropeptide Ff | 1.20e-05 | 69 | 98 | 5 | CID000123797 | |
| Drug | Dns-C6-Cho | 1.24e-05 | 11 | 98 | 3 | CID000124728 | |
| Drug | AC1L9NC9 | 1.24e-05 | 11 | 98 | 3 | CID000449642 | |
| Drug | dihydronereistoxin | 1.24e-05 | 11 | 98 | 3 | CID000121232 | |
| Drug | bipinnatin-B | 1.24e-05 | 11 | 98 | 3 | CID000127363 | |
| Drug | LJP 1082 | 1.24e-05 | 11 | 98 | 3 | CID003037609 | |
| Drug | phencyclidine | 1.34e-05 | 181 | 98 | 7 | CID000006468 | |
| Drug | GTS-21 | 1.36e-05 | 34 | 98 | 4 | CID005310985 | |
| Drug | thiacloprid | 1.36e-05 | 34 | 98 | 4 | CID000115224 | |
| Drug | l-Lobeline | 1.36e-05 | 34 | 98 | 4 | CID000003945 | |
| Drug | arecoline | 1.48e-05 | 72 | 98 | 5 | CID000002230 | |
| Drug | Tubocurarine,d | 1.48e-05 | 72 | 98 | 5 | CID000001210 | |
| Drug | atracurium | 1.53e-05 | 35 | 98 | 4 | CID000047319 | |
| Drug | EPTC | 1.53e-05 | 35 | 98 | 4 | CID000012968 | |
| Drug | AC1Q3ZOL | 1.59e-05 | 258 | 98 | 8 | CID000002376 | |
| Drug | diaminopyridine | 1.65e-05 | 12 | 98 | 3 | CID000020314 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 5.31e-12 | 16 | 90 | 6 | DOID:3635 (implicated_via_orthology) | |
| Disease | MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL | 8.09e-11 | 4 | 90 | 4 | C4084823 | |
| Disease | Lethal multiple pterygium syndrome | 2.74e-08 | 3 | 90 | 3 | cv:C1854678 | |
| Disease | Myasthenic Syndrome, Congenital, Fast-Channel | 2.74e-08 | 3 | 90 | 3 | C1837122 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 2.74e-08 | 3 | 90 | 3 | 253290 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.43e-07 | 16 | 90 | 4 | C0751885 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.54e-07 | 195 | 90 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.87e-07 | 17 | 90 | 4 | C0751883 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 3.03e-07 | 19 | 90 | 4 | C0751884 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 5.45e-07 | 6 | 90 | 3 | C1854678 | |
| Disease | Myasthenic Syndromes, Congenital | 8.21e-07 | 24 | 90 | 4 | C0751882 | |
| Disease | Congenital myasthenic syndrome | 3.24e-06 | 10 | 90 | 3 | cv:C0751882 | |
| Disease | Mood Disorders | 1.31e-05 | 168 | 90 | 6 | C0525045 | |
| Disease | Withdrawal Symptoms | 3.03e-05 | 58 | 90 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 3.03e-05 | 58 | 90 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 3.03e-05 | 58 | 90 | 4 | C0038587 | |
| Disease | Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency | 5.50e-05 | 4 | 90 | 2 | C1837092 | |
| Disease | Mental Depression | 1.31e-04 | 254 | 90 | 6 | C0011570 | |
| Disease | Ataxias, Hereditary | 2.55e-04 | 8 | 90 | 2 | C0004138 | |
| Disease | Depressive disorder | 2.62e-04 | 289 | 90 | 6 | C0011581 | |
| Disease | 2-ketocaprylate measurement | 4.07e-04 | 10 | 90 | 2 | EFO_0800110 | |
| Disease | Disorder of eye | 4.89e-04 | 212 | 90 | 5 | C0015397 | |
| Disease | pigmentation disease (is_implicated_in) | 4.97e-04 | 11 | 90 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | vascular endothelial growth factor measurement | 6.77e-04 | 56 | 90 | 3 | EFO_0004762 | |
| Disease | Cocaine Dependence | 8.81e-04 | 139 | 90 | 4 | C0600427 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.38e-03 | 157 | 90 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 1.97e-03 | 81 | 90 | 3 | C3711374 | |
| Disease | CCL11 measurement | 2.23e-03 | 23 | 90 | 2 | EFO_0005188 | |
| Disease | telomere length | 2.74e-03 | 313 | 90 | 5 | EFO_0004505 | |
| Disease | pseudotumor cerebri | 2.85e-03 | 26 | 90 | 2 | EFO_1001132 | |
| Disease | Depressive Symptoms | 2.85e-03 | 26 | 90 | 2 | C0086132 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPCVLTTLLAILVFY | 241 | P30926 | |
| LLPELCTFVVRVLFY | 31 | A0FGR9 | |
| PLFYIINILVPCVLI | 246 | Q07001 | |
| IPYLQSVIFLFVIRC | 1121 | Q8WWZ4 | |
| IFVLVLIIQLGVCLF | 1071 | Q4VNC1 | |
| PLFYVINIIAPCVLI | 241 | P07510 | |
| LFYTINLIIPCLLIS | 266 | Q15822 | |
| LFYLVNVIAPCILIT | 246 | P11230 | |
| CILITLLAIFVFYLP | 256 | P11230 | |
| AVIVLLAPIQYFIAT | 461 | O60706 | |
| ANAYFLCLLILQLIP | 56 | Q8TF62 | |
| CAVGLVLVLLYLFAP | 391 | Q86WK7 | |
| YLVPACIVVLIFLAF | 1591 | Q8IZY2 | |
| LFYVINIIVPCVLIS | 241 | Q04844 | |
| VICPAVLILASYLFI | 206 | Q8NH87 | |
| ETICRYNLPIILLVV | 466 | Q9UJ83 | |
| LIICNAIIDPLIYAF | 286 | Q01726 | |
| VPLFLVFLAIYNVTV | 26 | Q8NGL1 | |
| LFCVLGLYIAIPFLI | 76 | Q8N2K0 | |
| PLYFIVNVIIPCLLF | 231 | P02708 | |
| QLRIYLVSLPFVCLC | 311 | Q9NW15 | |
| DVLLQLVLRYLVPCN | 416 | Q8N612 | |
| CLLLLDVLVLPQEYF | 176 | Q8N6Y1 | |
| FLCIYPITLTGNLLI | 31 | Q9Y585 | |
| IFVVPSVCILVSYIL | 206 | Q8NHA8 | |
| VVLCFFVPCVVIYLR | 246 | Q8NGN3 | |
| LLVIQILLIVCFLPY | 251 | Q96P67 | |
| YICYVIILQPLRVLD | 36 | Q92604 | |
| VFTAILYCIPLRYIV | 926 | Q6DN14 | |
| CLILAAATIILYFIP | 801 | Q6DN12 | |
| LLANLVIFLLCFVPY | 236 | Q9H1C0 | |
| FLYAEVFVVLLLCIP | 11 | P51572 | |
| QYHLIIFVLIICIPS | 136 | Q9P1W3 | |
| LVCFAPYVITRLVEL | 251 | Q8NDV2 | |
| LQCVEKYLIYPAVVL | 1141 | Q9H6A9 | |
| CILNIVFSPFVLVII | 566 | Q63HM2 | |
| YPVILISLTIFLDCL | 196 | Q9Y5P1 | |
| ISHICAVLVFYIPII | 251 | Q9H2C8 | |
| FGVVLVIYLAPLCIS | 196 | Q9HCC8 | |
| VAIALFAPLLYVIEN | 386 | Q9UIX4 | |
| PQVVCTLKQLCILYL | 91 | Q5BKY1 | |
| ACVVILPLICFLLYK | 591 | Q3SXY7 | |
| LIGFVTPLLIVLYCT | 191 | Q9BXC1 | |
| ICAVIIFYLPIINLA | 246 | Q8NGJ7 | |
| ICAVIIFYLPIINLA | 246 | Q8NGJ6 | |
| LAVYIVPVIVLAACY | 206 | P30559 | |
| VICPAVLILASYLFI | 206 | P0C7N8 | |
| LVYPLAQVIIGCIKL | 431 | Q9Y3T9 | |
| LFAVPFAVILVCYVL | 206 | P41231 | |
| VLNQLRYPSVLLLVC | 126 | Q9H6S3 | |
| ALSLIAIVLVCFAPY | 226 | P46093 | |
| VLLICITVFLSYLPE | 246 | Q96MC6 | |
| AFVVPILIITVCYGL | 221 | P41143 | |
| PLGFILICYLKIVIC | 221 | Q99463 | |
| VFALCYLPISVLNVL | 306 | O43613 | |
| LVFAICYLPISILNV | 311 | O43614 | |
| ALTILYGFCIIPENI | 496 | O15354 | |
| ASCIILVFIFLRYPL | 211 | A6NMD0 | |
| LLPFYILVLIICFLS | 421 | Q7Z388 | |
| LRYFVLAPLCLYVVV | 371 | Q9NPG1 | |
| LFLFAVIVLQYVCPG | 161 | Q96MM7 | |
| FYPLVTFVLLLICIA | 356 | Q53GD3 | |
| LVYPALTFILLSICI | 371 | Q8NCS7 | |
| LLILLCVLNFLSPFY | 21 | Q9Y226 | |
| VYLPCLQNIFGVILF | 191 | Q9UHW9 | |
| LTNPVFVGYLCIVLL | 156 | Q7RTP0 | |
| VYLPCLQNIFGVILF | 126 | Q9H2X9 | |
| FSVPLLCIIVSYIRV | 206 | Q9P1Q5 | |
| FIFAFVIPVLIIIVC | 231 | P41145 | |
| QYPELQLFLFLLCLI | 51 | Q8NGV5 | |
| DLVYIVIFPQLLCVL | 411 | Q9GZV3 | |
| LIECPIFTYLRLQLL | 671 | Q08AM6 | |
| PYVVLICFLIRAFLL | 261 | Q9H2J7 | |
| PCLVTRAVYIDILFL | 1451 | Q6YHU6 | |
| GKVIYVLVLLPCFII | 291 | Q9GZN6 | |
| FGPLLVICLCYLLIV | 216 | P32745 | |
| LLVQYILPLVCLTVS | 216 | Q15761 | |
| QFLIYVILEILIFCI | 181 | Q9H841 | |
| CFIGYVLPLIIILIC | 201 | P32249 | |
| VLPLIIILICYSQIC | 206 | P32249 | |
| IILIIVVFVLCFTPY | 246 | P32249 | |
| VAILPLYLQLLLECF | 341 | Q8TDN2 | |
| LILLVFIIFVRCNPV | 466 | Q86UG4 | |
| CIYLQLLLFNPLVKT | 11 | P21583 | |
| AVLLQVICLYQKVVP | 556 | O60287 | |
| PVFLVALLPLAIVCY | 1161 | Q09428 | |
| LLVYCLLLFPQLDVS | 986 | Q96JQ2 | |
| LVLLLYAPVGFCLLV | 26 | Q9Y679 | |
| VILLDCFILVLYPDV | 61 | Q9NYW3 | |
| LVIQFPGLYFIICQL | 131 | P32971 | |
| LLNVVAPAYFLCISL | 6 | Q8N966 | |
| CIPYLGLILQDLTFV | 981 | Q13905 | |
| YLAICVLFNIILFLV | 101 | P23942 | |
| QVEVLVEYPLRCLVL | 641 | Q8IWV7 | |
| VEYPLRCLVLVAQVV | 646 | Q8IWV7 | |
| AAVVLQVCSLVLYPI | 121 | Q9BQJ4 | |
| CIFTALPLVTVVYLL | 241 | Q8TCU3 | |
| ICIVTYVLNFLLLII | 141 | Q8N0U8 | |
| GPILLCILVVASNIY | 826 | Q9H330 | |
| SCIFVLIVIYAIGPL | 386 | Q8TE54 | |
| PLQFLVVFCLALQLV | 6 | Q8IUB5 | |
| LVVLNVSVPCLLYVY | 496 | O76024 | |
| LNIIDCVAILPFYLE | 381 | Q14003 |